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It has been shown recently that PrP (prion protein) and the
calcium channel auxiliary α2δ subunits interact in neurons
and expression systems [Senatore, Colleoni, Verderio, Restelli,
Morini, Condliffe, Bertani, Mantovani, Canovi, Micotti, Forloni,
Dolphin, Matteoli, Gobbi and Chiesa (2012) Neuron 74, 300–
313]. In the present study we examined whether there was an effect
of PrP on calcium currents. We have shown that when PrP is co-
expressed with calcium channels formed from CaV2.1/β and α2δ-1
or α2δ-2, there is a consistent decrease in calcium current density.
This reduction was absent when a PrP construct was used lacking
its GPI (glycosylphosphatidylinositol) anchor. We have reported
previously that α2δ subunits are able to form GPI-anchored pro-
teins [Davies, Kadurin, Alvarez-Laviada, Douglas, Nieto-Rostro,
Bauer, Pratt and Dolphin (2010) Proc. Natl. Acad. Sci. U.S.A.
107, 1654–1659] and show further evidence in the present paper.
We have characterized recently a C-terminally truncated α2δ-1
construct, α2δ-1C, and found that, despite loss of its membrane
anchor, it still shows a partial ability to increase calcium currents
[Kadurin, Alvarez-Laviada, Ng, Walker-Gray, D’Arco, Fadel,
Pratt and Dolphin (2012) J. Biol. Chem. 1287, 33554–33566].
We now find that PrP does not inhibit CaV2.1/β currents formed
with α2δ-1C, rather than α2δ-1. It is possible that PrP and α2δ-1
compete for GPI-anchor intermediates or trafficking pathways,
or that interaction between PrP and α2δ-1 requires association in
cholesterol-rich membrane microdomains. Our additional finding
that CaV2.1/β1b/α2δ-1 currents were inhibited by GPI–GFP, but
not cytosolic GFP, indicates that competition for limited GPI-
anchor intermediates or trafficking pathways may be involved in
PrP suppression of α2δ subunit function.
Key words: α2δ, auxiliary subunit, calcium channel, GPI anchor,
prion protein.
INTRODUCTION
CaV (voltage-gated Ca2 + ) channels contain a pore-forming α1
subunit, which determines the main properties, both biophysical
and pharmacological, of the channels. For the CaV1 and CaV2
subfamilies, the α1 subunit is associated with a membrane-
anchored predominantly extracellular α2δ subunit (for a review,
see [1]) and a cytoplasmic β subunit (for reviews, see [2,3]).
The β subunits have been shown to enhance calcium channel
trafficking by binding to the I–II linker of the α1 subunits [4,5],
and thus inhibiting proteasomal decay as has been shown for the
CaV2.2 [6] and CaV1.2 [7] channels. In contrast, the mechanism
of enhancement of the CaV channel functional expression by α2δ
subunits has not been firmly established, although we have found
that it involves their von Willebrand Factor A domain [8], and
results in increased plasma membrane expression and active zone
targeting of the channel complex [8,9].
The major mechanism whereby α2δ subunits increase the
functional expression of calcium channels is due to an increase in
the amount of channel protein at the plasma membrane ([8,10] and
J.S. Cassidy and A.C. Dolphin, unpublished work). Furthermore,
it has been found that the α2δ subunits do not increase single
channel conductance or open probability [11,12], two other
mechanisms whereby macroscopic current could be increased.
Nevertheless, there are effects of α2δ subunits to increase
voltage-dependent inactivation and to hyperpolarize the voltage-
dependence of steady-state inactivation, providing evidence that
these subunits do remain associated with the functional channel
complex on the plasma membrane [8,13,14].
Mammalian genes encoding four α2δ subunits have been
identified (for reviews, see [3,15]). The topology of the α2δ protein
was first determined for α2δ-1, and is thought to generalize to
all four α2δ subunits (for reviews, see [1,16]). They all have
predicted N-terminal signal sequences, indicating that the N-
terminus is extracellular. The α2 and δ subunits are the product
of a single gene, encoding the α2δ pre-protein, which is post-
translationally cleaved into α2 and δ [17]. The extracellular α2
subunit then remains disulfide-bonded to the membrane-bound
δ subunit. Although α2δ subunits were originally described as
transmembrane proteins, we have shown previously that they can
form GPI (glycosylphosphatidylinositol)-anchored proteins [13].
The PrPC [normal cellular PrP (prion protein)] is a GPI-
anchored sialoglycoprotein [18] exposed on the outer leaflet of
the plasma membrane, that is widely distributed throughout the
nervous system [19,20]. Its normal physiological function is still
being elucidated [20] and genetic ablation of PrP KO (knockout)
only produces subtle phenotypes in mice [21,22]. However,
it appears to play a role in signal transduction [23], copper
binding [24], synaptic function [25] and myelin maintenance
[26]. Furthermore, misfolding of PrPC results in the formation of
the partially protease-resistant isoform PrPSc (PrP scrapie), which
accumulates in the brain and results in neurodegeneration, giving
rise to Creutzfeldt–Jakob disease [19,27]. PrPSc is both neurotoxic
and infectious. In the absence of PrPC, PrPSc cannot be generated
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and PrP-null mice do not propagate infectivity or develop patho-
logy on infection with PrPSc [28–30]. Thus it has been postulated
that the presence of PrPC in neurons is essential for the initiation of
a cascade of signalling events leading to prion disease pathology.
Initial evidence that the α2δ subunits are closely associated
with PrP came from the finding that the α2δ-1, α2δ-2 and α2δ-
3 subunits were co-immunopurified with PrP from the brains
of transgenic mice expressing Myc-tagged PrP [31]. The α2δ
subunits are expressed strongly in cholesterol-rich detergent-
resistant membranes [13,32], as is PrP [33,34], which may
represent the basis for their association. It has been shown
recently that α2δ-1 and PrP can co-immunoprecipitate from both
brain tissue and cell lines [35], and that the interaction between
pathogenic mutant PrP and α2δ-1 results in the intracellular
retention of both species [35].
We were interested to determine whether PrP co-expression
has any direct effect on calcium channel currents via a direct or
indirect effect on α2δ subunit processing or function. We therefore
utilized full-length and C-terminally truncated PrP and α2δ-1 to
examine the effect of these species on calcium channel functional
expression.
MATERIALS AND METHODS
Heterologous expression of cDNAs
The calcium channel cDNAs used were rat CaV2.1 (GenBank®
accession number M64373), mouse α2δ-2 (GenBank® accession
number AF247139), rat α2δ-1 (GenBank® accession number
M86621), α2δ-1 mid HA (haemagglutinin) [36], α2δ-1C–HA
[36], rat β4 (GenBank® accession number NM001105733) and
rat β1b [37]. The PrP constructs used (in pcDNA3) were
WT (wild-type) PrP (mouse) and GPI–PrP [38]. The GFP
constructs used were mut3 GFP [39] and GPI–GFP in pcDNA3
[40]. The cDNAs were in the pMT2 expression vector, unless
stated above. Mammalian tsA-201 cells were transfected with
the following cDNA combinations (Cav2.1/β1b/α2δ-1/PrP at
3:2:2:0.5 or Cav2.1/β4/α2δ-2/PrP at 3:2:2:1), with empty vector
replacing constructs not used unless otherwise stated, and
transfection was performed as described previously [41]. The
cDNA for GFP was also included to identify transfected cells
from which electrophysiological recordings and imaging were
performed, unless GPI–GFP was used.
Mice
Cerebella were obtained from C57BL/6J (WT) mice or from
Tg(WT-E1) mice expressing WT mouse PrP with an epitope
for the monoclonal antibody 3F4 at approximately 4-fold the
endogenous PrP level, referred to throughout the text as PrP
Tg(WT) [42], or from PrP-KO mice with a pure C57BL/6J
background (European Mouse Mutant Archive, Monterotondo,
Rome; EM:01723) [21].
Preparation of Triton X-100-insoluble membrane fractions [DRMs
(detergent-resistant membrane)]
All steps were performed on ice. One cerebellum was used as
the starting material from WT, PrP Tg(WT) and PrP-KO mice.
The cerebella were homogenized using a Teflon homogenizer in
MBS [Mes-buffered saline; 25 mM Mes (pH 6.5), 150 mM NaCl
and CompleteTM protease inhibitor cocktail (Roche)], containing
1% (v/v) Triton X-100 (Thermo Scientific), and left on ice
for 1 h. An equal volume of 90% (w/v) sucrose in MBS was then
added. The sample was transferred into a 13 ml ultracentrifuge
tube and overlaid with 10 ml of discontinuous sucrose gradient,
consisting of 35% (w/v) sucrose in MBS (5 ml) and 5% (w/v)
sucrose in MBS (5 ml). The sucrose gradients were centrifuged
at 138000 g for 18 h at 4 ◦C (Beckman SW40 rotor). Fractions
(1 ml) were subsequently harvested from the top to the bottom
of the tube. When necessary, protein fractions from the gradient
were washed free of sucrose by dilution in 25 volumes of ice-
cold PBS and ultracentrifugation (150000 g for 1 h at 4 ◦C) to
pellet the cholesterol-enriched microdomain material. Triton X-
100-insoluble protein was resuspended in deglycosylation buffer
and treated with PNGase F (peptide N-glycosidase F; Roche), as
described below.
Treatment of Triton X-100-insoluble protein fractions with PI-PLC
(phosphatidylinositol-specific phospholipase C)
Triton X-100-insoluble fractions from brain tissue were collected,
washed free of sucrose and centrifuged as described above.
The resultant pellet of Triton X-100-insoluble material was
resuspended in an appropriate volume of PI-PLC reaction
buffer [10 mM Tris/HCl (pH 7.4) and 150 mM NaCl containing
CompleteTM protease inhibitor cocktail (Roche)], to a final protein
concentration of ∼2 mg/ml. The samples were sonicated and
treated with 25 units of PI-PLC enzyme (Sigma) for 3 h at 37 ◦C.
Phase separation of PI-PLC-treated proteins using Triton X-114
Membrane-associated proteins were separated from soluble pro-
teins in two phases of Triton X-114 as described previously [43].
Briefly, the pellet of detergent-insoluble material was resuspended
in an appropriate volume of reaction buffer (final concentration
of ∼2 mg/ml of protein) and incubated with PI-PLC as described
above. Control experiments omitting the enzyme were also per-
formed. After PI-PLC incubation the samples were supplemented
with Triton X-114 (Thermo Scientific) to a final concentration of
1%. A cushion of 6% (w/v) sucrose, 10 mM Tris/HCl (pH 7.4),
150 mM NaCl and 0.06% Triton X-114 was placed at the bottom
of a 1.5 ml Eppendorf tube. The protein sample was then overlaid
on this sucrose cushion and the tube incubated for 3 min at 30 ◦C
and centrifuged at 300 g for 4 min at room temperature (20 ◦C) in
a swinging bucket rotor. Following centrifugation, the detergent
phase was present as an oily droplet at the bottom of the tube. Fresh
Triton X-114 was then added to the upper aqueous phase to 0.5%
and the procedure was repeated using the same sucrose cushion.
In the last step the aqueous phase was removed from the cushion,
supplemented with fresh Triton X-114 to 2% and subjected to
another centrifugation. The detergent phase of this last procedure
was discarded. The aqueous and detergent phases from this
procedure were adjusted to the equal volume with 10 mM
Tris/HCl (pH 7.4) and 150 mM NaCl plus protease inhibitors.
Acetone precipitation and PNGase F deglycosylation
To remove the remaining Triton X-114 in the detergent and
aqueous phases from the phase separation experiment the proteins
were precipitated by the addition of 4 volumes of ice-cold acetone
and subsequent incubation for 1 h at − 20 ◦C. The precipitated
material was centrifuged at 16000 g for 10 min and the pellet
was washed once with an acetone/water (4:1) mixture ( − 20 ◦C).
The pellets of the precipitated proteins were then resuspended
in 45 μl of PNGase F buffer [10 mM Tris/HCl (pH 7.5) and
150 mM NaCl supplemented with 75 mM 2-mercaptoethanol,
0.5% Triton X-100, 0.1% SDS and protease inhibitors]. A total
of 1 unit of PNGase F was added per 10 μl volume followed
by incubation at 37 ◦C for 5–12 h. The samples were then
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resuspended in an appropriate volume of SDS gel loading buffer
and heated for 10 min at 56 ◦C in order to terminate the reaction.
Immunoblotting
Western blotting was performed as described previously [41]. The
samples were resolved on either 3–8% Tris/acetate or 4–12%
Bis-Tris gels with the relevant buffer systems (Life Technologies).
The samples were then blotted on to PVDF membranes (Bio-
Rad Laboratories), blocked with 3% BSA in TBS provided with
0.5% Igepal and incubated with the following primary antibodies:
anti-α2-1 (1:1000 dilution; mouse monoclonal; Sigma), anti-
α2-2 (residues 102–117; rabbit polyclonal; [44]), anti-PrP (3F4
epitope), anti-PrP (residues 45–66; rabbit polyclonal; [45])
and anti-flotillin-1 (1:2000 dilution; mouse monoclonal; BD
Biosciences). The secondary antibodies used were goat anti-
mouse and goat anti-rabbit coupled to HRP (horseradish
peroxidase; Bio-Rad Laboratories).
Electrophysiology
Calcium channel expression in tsA-201 cells was investigated
by whole-cell patch-clamp recording essentially as described
previously [46]. The internal (pipette) and external solutions and
recording techniques were similar to those described previously
[47]. The patch pipette solution contained: 140 mM caesium
aspartate, 5 mM EGTA, 2 mM MgCl2, 0.1 mM CaCl2, 2 mM K2-
ATP and 10 mM Hepes, pH 7.2 at 310 mM mOsm, with sucrose.
The external solution for recording Ba2 + currents contained:
150 mM tetraethylammonium Br, 3 mM KCl, 1 mM NaHCO3,
1 mM MgCl2, 10 mM Hepes, 4 mM glucose and 1 mM BaCl2,
pH 7.4 at 320 mOsm, with sucrose. Pipettes of resistance 2–4 M
were used. An Axopatch 1D amplifier (Axon Instruments) was
used, and data were filtered at 1–2 kHz and digitized at 5–10 kHz.
Current records were subjected to leak and residual capacitance
current subtraction (P/8 protocol). Analysis was performed using
Pclamp 9 (Molecular Devices) and Origin 7 (Microcal Origin). All
comparisons between different groups of transfected cells were
performed in parallel on the same experimental days.
When stated, current–voltage (I–V) plots were fit with a
modified Boltzmann equation for determination of the voltage
for 50% activation (V50, activation) [48], and steady-state
inactivation curves were fit with a single Boltzmann function
for determination of the voltage for 50% inactivation (V50,
inactivation). Where data are given as means +− S.E.M., statistical
comparisons were performed using either Student’s t test or
ANOVA with the appropriate post-hoc test.
Xenopus oocytes were prepared, injected and utilized for
electrophysiology as described previously [49], with the following
exceptions. Plasmid cDNAs for the calcium channel α1, α2δ-1
and β1b subunits and for PrP were mixed at 2:1:2:x ratios at
1 μg/μl, where x = 2, 1 or 0.5 unless otherwise stated, and the
empty vector was included to maintain the total cDNA mixture
constant. A 9 nl volume was injected intranuclearly, after 2-fold
dilution of the cDNA mixtures. Recordings in Xenopus oocytes
were performed at 18 ◦C as described previously [48], and all
recordings were performed 48–60 h after injection for CaV2.2.
The Ba2 + concentration was 10 mM.
RESULTS
α2δ subunits and PrP show similar biochemical properties
We have shown previously that endogenous α2δ-1 and α2δ-2 are
strongly expressed in DRM fractions [13,32], as is PrP [18].
Therefore we prepared DRM fractions from the cerebella of WT,
PrP Tg(WT) and PrP-KO mice. We found the typical localization
of α2δ-1, α2δ-2 and also PrP in DRMs (Figure 1A).
It is well-established that PrP is GPI-anchored [18], and
our previous findings indicate that the α2δ subunits can form
GPI-anchored proteins [13]. One important piece of evidence
supporting this premise is that following PI-PLC treatment, both
endogenous α2δ subunits from the rat brain and heterologously
expressed α2δ proteins redistribute from the detergent phase into
the aqueous phase upon Triton X-114 phase separation [13]. This
demonstrates that PI-PLC treatment has converted the protein
into a hydrophilic species, most probably by removing the bulky
hydrophobic GPI anchor. To assess if the behaviour of α2δ proteins
in this phase-separation assay was affected by the presence or
absence of PrP, we concentrated the DRM fractions enriched in
both PrP and α2δ and subjected them to PI-PLC treatment as
described previously [13]. An aliquot of the initial DRM material
from the three mouse genotypes, before PI-PLC treatment, was
deglycosylated with PNGase F to demonstrate the presence of
α2δ-1 and α2δ-2 (Figure 1B).
PI-PLC treatment caused α2δ-1 and α2δ-2 to redistribute into
the aqueous phase upon Triton X-114 phase separation in all
three of the mouse genotypes tested (Figure 1C). As a control, the
PrP Tg(WT) samples were also blotted for PrP, and redistributed
similarly upon PI-PLC treatment (Figure 1D).
Importantly, the response of α2δ-1 and α2δ-2 to PI-PLC
treatment was not affected by the absence of PrP, in the PrP
KO cerebellar material (Figure 1C). It was also not affected by
the overexpression of PrP in the PrP Tg(WT) cerebellar material
(Figure 1C). These data indicate that although PrP has been
reported to interact with α2δ subunits [35], interaction with PrP
was not responsible for the presence of α2δ subunits in DRM
fractions or their redistribution into the aqueous phase following
PI-PLC cleavage of GPI-anchor sites.
Co-expression of PrP decreased calcium channel currents
containing CaV2.1/β4/α2δ-2
We then examined whether PrP would influence the ability of α2δ
to increase calcium channel currents. We expressed CaV2.1/β4
and α2δ-2 to mimic the calcium channel combination present in
cerebellar Purkinje cells, either with or without PrP. We found
that PrP co-expression produced a moderate, but consistent,
reduction in peak calcium channel currents at + 10 mV of
approximately 34%, although the currents in the presence of PrP
and α2δ remained significantly larger than those in the absence
of α2δ (Figures 2A–2C). The voltage-dependence of activation
of the CaV2.1/β4/α2δ-2 currents in the presence of PrP was also
significantly depolarized, compared with in its absence, although
not to the same extent as in the absence of α2δ (Figure 2D).
Similarly, the voltage-dependence of steady-state inactivation of
CaV2.2/β4/α2δ-2 was depolarized significantly in the additional
presence of PrP (Figures 2E and 2F). All these effects are
indicative of a reduced enhancement by α2δ-2 of CaV2.1/β4
calcium channel currents when PrP was co-expressed.
Co-expression of PrP decreased calcium channel currents
containing CaV2.1/β1b/α2δ-1
We then examined whether PrP would also inhibit calcium
channel combinations containing α2δ-1, and tested whether any
effect could be due to the demonstrated interaction at the level
of the two polypeptides [35] or a result of lipid anchoring and
co-localization in the same cholesterol-rich microdomains. We
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Figure 1 PI-PLC treatment and phase separation of α2δ-1, α2δ-2 and PrP in mouse cerebella
(A) DRM fractions from WT (left-hand panel), PrP Tg(WT) (middle panel) and PrP KO (right-hand panel) mouse cerebella were prepared as described in the Materials and methods section. Aliquots
were resolved on 3–8 % Tris/acetate (to resolve α2δs) or 4–12 % Bis-Tris gels (to resolve PrP in the same samples), and analysed by Western blotting (WB) with relevant antibodies as indicated.
The full profile is not shown, but only the fractions of the sucrose gradient corresponding to DRMs identified by the presence of flotillin-1 (fractions 4–7 harvested from the top). The anti-α2δ-1
and anti-α2δ-2 antibodies recognize the α2-1 and α2-2 moieties. (B) Aliquots of concentrated DRM fractions from WT (left-hand panel), PrP Tg(WT) (middle panel) and PrP KO (right-hand panel)
cerebella were treated with PNGase F and analysed by Western blotting with the indicated antibodies. (C) DRM fractions analysed in (A) were subjected to PI-PLC treatment and Triton X-114 phase
separation (see the Materials and methods section), followed by PNGase F deglycosylation. The proteins remaining in the aqueous (aq) and detergent (det) phase were then resolved on 4–12 %
Bis-Tris gels and analysed with the indicated antibodies. Lanes 1 and 2 in each panel are from detergent phase fractions, whereas lanes 3 and 4 are from the respective aqueous phase, treated or not
with PI-PLC as indicated. (D) The PrP Tg(WT) fractions from (C, middle panel) were also blotted for PrP using the 3F4 antibody. Molecular mass is shown on the right-hand side of the gels in kDa.
therefore expressed CaV2.1/β1b/α2δ-1 with either WT PrP or
anchorless PrP, truncated at the GPI-anchor site (GPI–PrP)
[38]. We observed that co-expression with WT PrP reduced the
peak calcium channel currents to a similar extent (39%) to
that shown for the CaV2.1/β4/α2δ-2 combination (Figures 3A–
3C), whereas GPI–PrP had no effect on the CaV2.1/β1b/α2
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Figure 2 Effect of PrP on CaV2.1/β4/α2δ-2 calcium channel currents
(A) Current–voltage (I–V ) relationships for IBa recorded from tsA-201 cells expressing CaV2.1/β4/α2δ-2 (; n = 25), CaV2.1/β4 alone (; n = 7) and CaV2.1/β4/α2δ-2/WT PrP (; n = 23). The
ratio of cDNAs used for transfection for CaV2.1/β4/α2δ-2/WT-PrP was 3:2:2:1, with empty vector used where α2δ or PrP was absent. (B) Examples of families of IBa current traces resulting from step
potentials from − 100 mV to between − 30 and + 15 mV in 5 mV increments for CaV2.1/β4/α2δ-2 (top panel), CaV2.1/β4 alone (middle panel) and CaV2.1/β4/α2δ-2/WT PrP (bottom panel). (C)
Individual peak IBa currents at + 10 mV, expressed as the mean +− S.E.M. percentage of the control condition with WT α2δ-2 and CaV2.1/β4/α2δ-2 (; n = 25), CaV2.1/β4 alone (; n = 7) and
CaV2.1/β4/α2δ-2/WT PrP (; n = 23). **P < 0.01 and ***P < 0.001. (D) Voltage-dependence of activation (V 50 activation) determined by fitting a modified Boltzmann function to the individual
I–V relationships shown in (A) for CaV2.1/β4/α2δ-2 (black bar), CaV2.1/β4 alone (white bar) and CaV2.1/β4/α2δ-2/WT PrP (grey bar). *P < 0.05 and **P < 0.01. (E) Steady-state inactivation
curves for IBa recorded from cells expressing CaV2.1/β4/α2δ-2 (; n = 12), CaV2.1/β4 alone (; n = 4) and CaV2.1/β4/α2δ-2/WT PrP (; n = 8). (F) Voltage-dependence of steady-state
inactivation (V 50 inactivation) determined by fitting a Boltzmann function to the individual steady-state inactivation relationships for the data shown in (E); CaV2.1/β4/α2δ-2 (black bar), CaV2.1/β4
alone (white bar) and CaV2.1/β4/α2δ-2/WT PrP (grey bar). **P < 0.01; NS, not significant. All statistical differences were determined by one-way ANOVA and Dunnett’s multiple comparison test.
δ-1 calcium channel currents (Figures 3A–3C). In these
experiments WT PrP did not produce a significant depolarization
of the voltage-dependence of activation of the currents
(Figure 3D).
In another expression system, Xenopus oocytes with
microinjected cDNAs and where the ratio of the different
constructs can be controlled accurately, the effect of PrP to reduce
CaV2.2/β1b/α2δ-1 calcium channel currents was observed at an
α2δ-1/PrP ratio of 1:1, but not at 2:1 or 4:1 (Figures 3E and 3F),
indicating that it was dependent on the amount of PrP expressed
relative to α2δ. Taken together, these results suggest that the
effect of PrP to reduce calcium channel currents is concentration-
dependent, and the presence of a GPI anchor on PrP may be
essential for the observed reduction in the functional expression
of calcium currents.
Membrane anchoring of both PrP and α2δ-1 is required for calcium
channel current inhibition by PrP
In order to test the importance of membrane anchoring of both
α2δ-1 and PrP on the inhibition by PrP we expressed CaV2.1/β1b
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Figure 3 Effect of PrP constructs on CaV2.1/β1b/α2δ-1 calcium channel currents
(A) Examples of families of IBa current traces resulting from step potentials from − 90 mV to between − 30 and + 10 mV in 5 mV steps for CaV2.1/β1b/α2δ-1 alone (top panel) with WT PrP
(middle panel) or with GPI–PrP (bottom panel). The ratio of cDNAs used for the transfection of CaV2.1/β1b/α2δ-1/PrP was 3:2:2:1, with empty vector used where α2δ or PrP was absent. (B) I–V
relationships for IBa recorded from tsA-201 cells expressing CaV2.1/β1b/α2δ-1 alone (; n = 28) with WT PrP (; n = 19) or with GPI–PrP (; n = 13). (C) Individual mean +− S.E.M. peak IBa
currents at + 5 mV for CaV2.1/β1b/α2δ-1 alone (; n = 28) with WT PrP (; n = 19) or GPI–PrP (; n = 13). **P < 0.01. (D) V 50 activation for CaV2.1/β1b/α2δ-1 alone (black bar) with WT
PrP (white bar) or with GPI–PrP (grey bar). All statistical differences were determined by one-way ANOVA and Dunnett’s multiple comparison test. (E and F) CaV2.2/β1b/α2δ-1 was expressed in
Xenopus oocytes either alone or together with PrP at the ratios shown. (E) Representative current traces elicited by steps to test potentials between − 25 and + 10 mV in 5 mV steps from a holding
potential of − 100 mV for CaV2.2/β1b/α2δ-1/PrP (1:0.25; upper panel) or CaV2.2/β1b/α2δ-1/PrP (1:1; lower panel). The residual voltage clamp transients have been truncated. (F) Peak currents
measured at + 10 mV for three α2δ-1/PrP ratios plotted as the mean +− S.E.M. percentage of the mean control IBa recorded in the absence of PrP in the same experiment. α2δ-1/PrP 1:1 (black
bar; n = 6), α2δ-1/PrP ratio 1:0.5 (grey bar; n = 18), α2δ-1/PrP ratio 1:0.25 (white bar; n = 20) and mean normalized control for α2δ-1 in the absence of PrP (hatched bar; n = 21). *P = 0.016
between the individual conditions and their respective control condition performed in the same experiment as determined by Student’s t test.
with either WT α2δ-1 or anchorless α2δ-1 (α2δ-1C–HA),
together with either WT PrP or anchorless PrP truncated at the
GPI-anchor site (GPI–PrP). We have shown previously that
an anchorless form of α2δ-1, although being mainly secreted,
is still able to promote an increase in calcium channel currents
compared with no α2δ, although to a smaller extent than WT
α2δ-1 [36]. In the present study we obtained the surprising result,
shown in Figures 4(A)–4(C), that, whereas WT PrP inhibited
calcium channel currents in the presence of WT α2δ-1, it did
not produce any reduction in the presence of anchorless α2δ-
1C–HA (Figure 4C). In agreement with the data shown in
Figure 3, GPI–PrP did not produce any inhibition of calcium
c© The Authors Journal compilation c© 2014 Biochemical Society© 2014 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/)
which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Functional interaction between prion protein and α2δ 371
Figure 4 Comparison of the effect of PrP constructs on calcium channel currents containing α2δ-1 or anchorless α2δ-1
(A) I--V relationships for IBa recorded from tsA-201 cells expressing CaV2.1/β1b/α2δ-1 alone (; n = 16) with WT PrP (; n = 10) or GPI–PrP (; n = 14) or cells expressing
CaV2.1/β1b/α2δ-1C alone (; n = 11) with WT PrP (; n = 13) or GPI–PrP (; n = 15). The ratio of cDNAs was the same as in Figure 3(A). (B) Examples of families of IBa current
traces resulting from step potentials from − 90 mV to between − 30 and + 10 mV in 5 mV steps for CaV2.1/β1b/α2δ-1 alone (top left-hand panel) or α2δ-1C alone (top right-hand panel) with
WT PrP (middle panel) or GPI–PrP (bottom panels). (C) Peak IBa currents (means +− S.E.M.) for the data shown in (A) for CaV2.1/β1b with α2δ-1 (solid bars) or with α2δ-1C (hatched bars)
either alone (black bars) or with WT PrP (light grey bars), or GPI-PrP (dark grey bars). *P < 0.05 as determined by one-way ANOVA and Bonferroni’s post-hoc test. (D) Western blot of α2δ-1
(upper panels; 4–12 % Bis-Tris gel) co-expressed (1:1) with WT PrP (left-hand lane), GPI–PrP (middle lane) or empty vector (right-hand lane; con). PrP expression is shown in the lower panel
(4–12 % Bis-Tris gel). The lower expression of GPI–PrP in the cell lysate is because much of it is secreted [53]. (E) Western blot of α2δ-1C in medium (upper panels; 3–8 % Tris/acetate gel)
and cell lysate (lower panels; 4–12 % Bis-Tris gel) co-expressed (1:1) with PrP (left-hand panels), GPI–PrP (middle panel) or empty vector (right-hand panels; con). In both (D) and (E), all three
lanes are from the same blots from which irrelevant lanes have been excised and the molecular mass is given on the right-hand side in kDa.
channel currents formed with WT α2δ-1 (Figure 4C). Similarly
GPI–PrP did not produce any reduction in the currents formed
with anchorless α2δ-1C–HA (Figure 4C). We found from
Western blotting that the WT and truncated α2δ and PrP species
used are all well-expressed in tsA-201 cells (Figures 4D and
4E), and lack of expression therefore could not account for
the lack of effect of the truncated constructs when expressed
together.
This result suggests either that association of the α2δ and PrP
proteins in the plasma membrane, and potentially in the same
cholesterol-rich membrane microdomains, facilitated by their
GPI anchoring, is essential for the inhibition of calcium currents
observed or that there is competition between α2δ-1 and PrP for
the GPI-anchor intermediates, resulting in less maturation of α2δ
subunit in the presence of PrP. We therefore examined whether
the effect of PrP might be related to the GPI anchor and tested the
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effect of an unrelated protein engineered to contain a GPI anchor
(GFP–GPI). We found that co-expression of GFP–GPI markedly
reduced calcium channel currents formed by CaV2.1/β1b/α2δ-1
compared with the co-expression of cytosolic GFP, and in this
experiment GPI–PrP again had no effect (Figure 5A). This
result is in agreement with the hypothesis that overexpression
of a GPI-anchored protein can produce this inhibition. We then
compared the level of α2δ-1 expression in the presence of co-
expressed GFP–GPI and cytosolic GFP (Figure 5B). In all cases
substantial α2δ-1 was co-expressed.
DISCUSSION
In the present study we found that when PrP is co-expressed with
CaV2.1 calcium channels together with a β-subunit and either α2δ-
1 or α2δ-2, it produces a modest reduction in the expressed calcium
channel currents. This reduction in calcium channel currents
involves the membrane anchoring of PrP, as it is absent when
PrP is truncated prior to its GPI-anchor site. Thus GPI–PrP did
not inhibit currents formed by the expression of CaV2.1/β1b/α2δ-
1. This result suggests that the process might involve competition
for pathways associated with the GPI anchoring of PrP, which
might relate to our finding that α2δ subunits form GPI-anchored
proteins [13]. The results of the present study reinforce that
view, since native cerebellar α2δ-1, α2δ-2 and PrP all behave
similarly following PI-PLC treatment and phase separation, being
concentrated in the aqueous phase (Figure 1), which is supportive
of evidence for GPI anchoring.
We therefore utilized an α2δ-1 subunit truncated at the predicted
membrane attachment site (α2δ-1C), which, as we have shown
recently, is not an integral membrane protein [36]. We have
characterized α2δ-1C and found that, despite being mainly
secreted, it still shows a partial ability to enhance calcium
channel currents and to be associated extrinsically with the plasma
membrane [36]. It is therefore possible that α2δ-1 enhances
calcium currents by two mechanisms, one involving a trafficking
process that is still maintained by anchorless α2δ-1C, and
another mechanism that requires its membrane anchoring, for
example a process that stabilizes channel complexes in the plasma
membrane.
Importantly, we also found in the present study that WT PrP
does not inhibit calcium channel currents when α2δ-1C was
substituted for WT α2δ-1. This suggested to us two possibilities.
First, PrP and α2δ-1 may compete for GPI-anchor intermediates
or subsequent trafficking processes specific for GPI-anchored
proteins when both are overexpressed. Secondly, the interaction
between PrP and α2δ-1 with other protein and lipid components
in cholesterol-rich membrane microdomains [50,51] might be
involved in the suppression of currents. Thus when either PrP
or α2δ-1 is devoid of the lipid anchor no suppression occurs.
It is possible that WT α2δ-1 and PrP interact indirectly via
an intermediary trafficking protein and compete for binding to
that protein, whereas this does not occur when one of them
is not membrane-anchored. Nevertheless, the additional finding
that CaV2.1/β1b/α2δ-1 currents were also inhibited by GPI–GFP
(when compared with the control GFP) suggests that the presence
of a GPI anchor might be an important common denominator
in this process. Only approximately 150 proteins are known
to be GPI-anchored, and the GPI synthetic pathway, involving
multiple enzymatic steps in the ER (endoplasmic reticulum) and
Golgi, is likely to have limited capacity in mammalian cells
[52]. Overexpression of multiple GPI-anchored proteins in the
same cell might lead to saturation of limited resources. Further
studies will be necessary to determine whether overexpression
Figure 5 Effect of GPI–GFP on CaV2.1/β1b/α2δ-1 calcium channel currents
(A) I–V relationships for IBa recorded from tsA-201 cells expressing CaV2.1/β1b/α2δ-1 with
GFP (; n = 9), GPI–GFP (; n = 9), or GFP and GPI–PrP (; n = 6). The broken line
indicates the level of IBa observed for CaV2.1/β1b/α2δ-1 plus WT PrP from Figure 3(B).
***P < 0.001 between the peak IBa when GPI–GFP was co-expressed compared with when GFP
was co-expressed (Student’s t test). (B) Western blot of α2δ-1 (upper panels) co-expressed
(1:1) with GFP–GPI (lane 1), GFP (lane 2) or empty vector (lane 3; con). GFP expression is
shown in the lower panel. All three lanes are from the same blots from which irrelevant lanes
have been excised and the molecular mass is given on the right-hand side in kDa.
of other GPI-anchored proteins disrupts the function of α2δ
within membrane microdomains, or possibly competes with it
for GPI transamidase enzymes, GPI-anchoring intermediates or
trafficking proteins subsequent to GPI anchoring. Taken together,
the results of the present study provide supporting evidence
that α2δ-1 can be GPI-anchored. More generally the results
point to a competitive interaction between GPI-anchored proteins
for resources that determine their level of post-translational
processing or expression on the plasma membrane.
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